Osidem Uses, Dosage, Side Effects and more

Osidem is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.

Trade Name Osidem
Generic IDM-1
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Ovarian cancer

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share